Biotechnology Innovation Organization– tag –
-
APAC’s Biomanufacturing Ascent: Australia Pioneers Viral Vector Production for Gene Therapies
Industry Publication Australia Overview The Asia-Pacific (APAC) region is rapidly accelerating its specialized manufacturing capabilities for high-value modalities like viral vectors and cell therapies, moving beyond traditional API prod... -
AGC Biologics Commits Half of New Yokohama Biomanufacturing Plant to Major Long-Term Deal
Megaproject Japan Overview AGC Biologics has secured a significant multi-million dollar, long-term commercial manufacturing contract with an undisclosed pharmaceutical firm for its new Yokohama facility, set to open in 2027. This landmar... -
Cell & Gene Therapy Manufacturing Faces Deepening Bottlenecks: AmplifyBio, Exothera Close; Thermo Fisher Cuts Viral Vector Jobs, but FDA Eases Regulations to Support Growth
Endpoints News Global Overview Despite cell and gene therapies becoming a commercial reality, manufacturing remains the primary bottleneck. The CDMO sector is struggling with overcapacity and underfunding, leading to closures like Amplif... -
US Department of Energy’s ‘GENESIS MISSION’ Aims for Bioprocess Autonomy via AI and Digital Twins, Targeting Enhanced Yields and Cost Reduction
Department of Energy USA Overview The U.S. Department of Energy's 'GENESIS MISSION' seeks to connect biological design with manufacturing outcomes by integrating AI with experiments, structural analysis, models, biodiversity discovery, a... -
Beckman Coulter Showcases BioLector XT Micro Bioreactor and Biomek i5 Automated Liquid Handler to Accelerate Precision Fermentation and Alternative Protein Research
Beckman Coulter Life Sciences (YouTube) USA Overview Chris Saenz of Beckman Coulter Life Sciences introduced key technologies accelerating early-stage microbiology engineering for precision fermentation and alternative proteins. The BioL... -
FDA Approves Orca Bio’s Precision-Engineered Cell Therapy Tregzi (Orca-T) for Allogeneic Transplant in Adults with Hematological Malignancies
CliniExpert USA Overview The U.S. FDA has approved Orca Bio’s precision-engineered cell therapy, Tregzi™ (Orca-T®), for allogeneic transplant in adult patients with hematological malignancies. Tregzi is a personalized therapy manufacture... -
Kincell Bio Inaugurates and Expands State-of-the-Art GMP Cell Therapy Manufacturing Facilities in Gainesville and Research Triangle Park
Kincell Bio USA Overview Kincell Bio has opened and expanded GMP cell therapy manufacturing facilities in Gainesville, Florida, and Research Triangle Park, North Carolina, designed to support both autologous and allogeneic cell therapies... -
Kincell Bio Unveils Scalable Allogeneic Cell Therapy Manufacturing Platform for Large-Scale Production with Closed-System Automation
Kincell Bio USA Overview Kincell Bio has launched a scalable allogeneic cell therapy manufacturing platform designed for large-volume production, efficient cell expansion, and closed-system automation. This platform supports diverse cell... -
Creative Life Science Unveils PIC/S GMP-Compliant Cell Therapy Platform at BIO Asia-Taiwan 2026, Bolstered by New Taiwan Regenerative Medicine Laws
PR Newswire Taiwan Overview According to PR Newswire, Creative Life Science is showcasing its PIC/S GMP-compliant cell therapy materials and manufacturing platform at BIO Asia-Taiwan 2026. The company's Zhubei biomanufacturing facility s... -
Bio-Engine Launches New MSC Culture Media, Achieving 15.1-Hour Doubling Time and 2.8-Fold Exosome Yield Increase
BioEngine Sci-Tech Co, Ltd. China Overview Bio-Engine Sci-Tech Co, Ltd. announced the launch of two new Mesenchymal Stem Cell (MSC) culture medium products: the Omni-Expansion MSC Culture Kit and Exo MSC CD Exosome Expression Kit. Design...
